Dye Imaging for Tenosynovial Giant Cell Tumor Surgery
Treatments studied
Part of Bones, joints & muscles, Cancer clinical trials.
This trial tests whether a special dye (Indocyanine Green) used during surgery can help doctors see Tenosynovial Giant Cell Tumors more clearly. It may help make the surgery more precise.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a confirmed diagnosis of Tenosynovial Giant Cell Tumor (a growth in the tissue around tendons) from a biopsy or MRI.
- You must be scheduled for surgery to remove the tumor.
- You cannot have a severe allergy to Indocyanine Green (a dye used during the procedure) or iodine.
- You must not have severe liver problems.
- You cannot be pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses a special dye called indocyanine green (ICG) during surgery to make giant cell bone tumors glow, helping doctors remove them more accurately. It may lead to better surgical outcomes for people with this tumor type.
This trial uses a special dye (ICG) and a camera to help surgeons see the tumor better during surgery for giant cell tumors of bone in the arms or legs. The goal is to remove all of the tumor while saving as much healthy bone as possible.
This study uses a special dye that makes tumors glow during surgery, helping your surgeon see exactly what to remove and what to leave. It aims to make surgery more precise and safer for people with bone or soft tissue tumors.
This early-stage study tests an intraoperative imaging approach called “TumorGlow” to help surgeons better identify tumor tissue during surgery. It may help improve the completeness of tumor removal and reduce the chance of recurrence in certain patients.
This trial tests a dye called indocyanine green (ICG) that makes cancer cells glow under a special camera during surgery. It may help doctors remove more cancer and leave healthy tissue alone.
This trial tests whether a special dye (ICG) seen during your surgery can help doctors better identify the edges of a tumor in bone or soft tissue. It may help ensure as much of the tumor is removed as safely as possible.
Hear when a new Tenosynovial Giant Cell Tumor trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.